LTM-16667-36318
3 vaccinations
2 coded responses
25 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 231 / VA
- Registered
- 2021-04-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
U28-48189-97833
Child or adolescent in my care · Male · 2021-11-06
X8D-34000-62013
Child or adolescent in my care · Male · 2022-06-20
Timeline
-
2021-03-22
Dose 1 — Pfizer-BioNTech
-
2021-04-12
Dose 2 — Pfizer-BioNTech
-
2021-04-15
Registered in v-safe
- 2021-04-15
- 2021-04-16
- 2021-04-18
- 2021-04-21
- 2021-04-26
- 2021-05-05
- 2021-05-10
-
2021-05-17
Survey response — day 35, dose 2MedDRA: Hypersensitivity, Nasal congestion, Nasopharyngitis, Rhinorrhoea, Sneezing, Throat irritation — Feeling: Good · Be unable to do your normal daily activitiesFree text: Severe allergies/slight cold. Runny/stuffy nose, sneezing, itchy throat. Temperature of 99°.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-24
- 2021-07-12
- 2021-10-11
-
2021-12-01
Dose 3 — Pfizer-BioNTech
-
2021-12-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-04
- 2021-12-05
- 2021-12-06
- 2021-12-07
- 2021-12-08
- 2021-12-15
- 2021-12-22
- 2021-12-29
- 2022-01-05
- 2022-01-12
-
2022-03-02
Survey response — 3 months, dose 3MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-03-02
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-03-03
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-06-01
- 2022-12-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Pfizer-BioNTech | |
| 2 | 2021-04-12 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-02 | Successful 2022-03-03 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 8 — day 35, dose 2
Symptoms: Severe allergies/slight cold. Runny/stuffy nose, sneezing, itchy throat. Temperature of 99°.
Release 11 — 3 months, dose 3
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Hypersensitivity | ○ | ✓ | ○ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SD | Throat irritation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release